EZH2 and glioblastoma: ,56,57 In glioblastoma, the upregulation of METTL3 upon temozolomide treatment led to increased m6A methylation of histone modifiers, including EZH2 and HDAC2,8 known to play a role in the development of resistance to the drug.58